Search:

< Go Back

Clintrax Global, Inc. Announces Addition to Executive Team
AlloSource® Announces Milo Metcalf As Vice President Of Operations
PTC Therapeutics to Participate at Upcoming Investor Conferences
Neurotrope To Host Conference Call
Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023
PAREXEL International To Present At Baird Healthcare Conference
BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market
Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark
Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research
Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents
KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema
Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies
Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders English
NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING
Global Cell and Tissue Culture Supplies - Strategic Business Report 2014
Geisinger investigator nominated for federal award
Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019
Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014
New England Biolabs® Introduces New Ribosomal RNA Depletion Technology from Genomic Health
CVac™ CAN-003 Abstract Accepted For Poster Presentation At The Society For Immunotherapy Of Cancer Annual Meeting
CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board
Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014
Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office
Oramed Granted Patent in Spain for Oral Administration of Insulin
Cellular Research Launches Early Access Program for Precise™ Assays
Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting
iCo Therapeutics Announces Positive Oral Amphotericin B Study Results
Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC
Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market
Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live
SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost
Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc.
Bioseparation Systems for Global Biopharmaceutical Markets
PDL BioPharma Announces Second Quarter 2014 and Year to Date Financial Results English
Pharmacyclics Appoints Chief Commercial Officer
Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research
Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 English
AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards
TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014
Hult Prize Finalists Complete Start-Up Boot Camp, Prepare to Present to President Clinton for US1M Prize
Dyadic International Files Form 10 Registration Statement
Qionglai Facility (QLF) Schedules September for GMP Examination
WuXi Facility Passes FDA Inspection for Manufacture of API
Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics
Immune Targeting Systems and WCCT Global Announce a New Influenza A H1N1 Virus to Support the Experimental Human Viral Challenge Model
HUYA Bioscience International Announces Partnership with Changzhou Center for Biotech Development
Succeeding in Global Strategic Marketing for Strong Oncology Launches
Best Practices Launches 2014-2015 Medical Affairs Consortium Survey
Resverlogix Corp. Closes Additional $30 million from Citibank Loan English English

< Prev Next >
PR Newswire - United Business Media